APPLICATION
ANDA078357
TYPE
ANDA
ORIGINAL APPROVAL
2010-02-19
LATEST ACTION
2019-10-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
DESLORATADINEPrescription
DESLORATADINE 5MG · TABLET · ORAL
Approval history
2019-10-18Labeling · Supplement 5 · standardAP
2015-02-11Labeling · Supplement 4 · standardAP
2013-12-20Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.